Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Atrial Fibrillation
Interventions
DRUG

Nifedipine,

Nifedipine 30-60mg/day

DRUG

Telmisartan

Telmisartan 80-160mg/day

Trial Locations (1)

400010

2ndChongqingMU, Chongqing

All Listed Sponsors
lead

The Second Affiliated Hospital of Chongqing Medical University

OTHER

NCT01435161 - Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF | Biotech Hunter | Biotech Hunter